Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-Sequencing of HEK293 During Adeno-Associated Virus Production [EXPA]

ABSTRACT: Recombinant viral vectors such as adeno-associated viruses (AAV) have emerged as a key tool in gene therapy applications. Despite extensive research efforts aimed at increasing production yields, the intricate molecular mechanisms that govern the synthesis of viral vectors within host cells remain largely unknown. The interplay between viral replication and cellular biosynthetic processes is complex and not fully understood, which poses challenges for effective manipulation. This study uses transcriptomics and RNA sequencing to investigate the cellular processes underlying viral vector production. Transcriptomics examines RNA molecules and their role in gene expression and has become invaluable in modern biological research. The advent of cost-effective, high-throughput sequencing technologies enables the comprehensive analysis of transcriptomes, providing valuable insights into gene regulation and cell signalling pathways. This study takes a strategic approach to deciphering the cellular mechanisms involved in viral vector production by utilising RNA-Seq data from a commercially available HEK293 suspension cell line. This study emphasises the importance of data-driven methodologies in advancing cell line development and optimising viral vector production.

ORGANISM(S): Homo sapiens

PROVIDER: GSE305359 | GEO | 2025/08/14

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

RNA-Sequencing of HEK293 During Adeno-Associated Virus Production [EXPB]

Project description:Recombinant viral vectors such as adeno-associated viruses (AAV) have emerged as a key tool in gene therapy applications. Despite extensive research efforts aimed at increasing production yields, the intricate molecular mechanisms that govern the synthesis of viral vectors within host cells remain largely unknown. The interplay between viral replication and cellular biosynthetic processes is complex and not fully understood, which poses challenges for effective manipulation. This study uses transcriptomics and RNA sequencing to investigate the cellular processes underlying viral vector production. Transcriptomics examines RNA molecules and their role in gene expression and has become invaluable in modern biological research. The advent of cost-effective, high-throughput sequencing technologies enables the comprehensive analysis of transcriptomes, providing valuable insights into gene regulation and cell signalling pathways. This study takes a strategic approach to deciphering the cellular mechanisms involved in viral vector production by utilising RNA-Seq data from a commercially available HEK293 suspension cell line. This study emphasises the importance of data-driven methodologies in advancing cell line development and optimising viral vector production.

2025-08-14 | GSE305360 | GEO

Response of mouse liver to Adenovirus, Helper Dependent Adenovirus, and Adeno-Associated Virus

Project description:Understanding host responses to viral gene therapy vectors is necessary for the development of safe and efficacious in vivo gene transfer agents. We describe the use of high-density spotted complementary DNA microarrays in monitoring the in vivo host transcriptional responses in mouse liver upon administration of either a "first-generation"adenoviral (Ad) vector, a helper-dependent "gutless" adenoviral (HD) vector, or an adeno-associated viral (AAV) vector containing human factor IX (hFIX) expression cassettes. Since HD and AAV do not contain any viral genes, they allow us to assess the host response to the viral capsid and packaged nonviral DNA in whole animals. Comparison of the host response to Ad and HD helps assess the importance of leaky adenoviral gene expression. While all three vectors induced characteristic temporally sequenced programs of gene expression, the gene expression programs induced by the Ad and HD adenovirus vectors were remarkably similar, including the induction of a prominent type I interferon (IFN)-dependent cluster within 6 hours of administration. In contrast, the AAV-based vector caused far fewer alterations of host-gene expression. Our results indicate that recognition of the Ad capsid or double-stranded DNA (of nonviral origin) in the vector elicits a robust type I IFN response that is, however, not elicited by AAV-derived vector transduction.

2009-05-13 | GSE16047 | GEO

Response of mouse liver to Adenovirus, Helper Dependent Adenovirus, and Adeno-Associated Virus

2010-06-25 | E-GEOD-16047 | biostudies-arrayexpress

Identifying a novel retinal pigment epithelium specific adeno-associated virus vector

Project description:Retinal Pigment Epithelium (RPE) are crucial for maintaining retinal homeostasis and the visual cycle. Currently, there are no effective treatments for blinding retinal diseases caused by RPE cell degeneration. Gene therapy presents a promising approach, but no gene therapy vectors specifically targeting RPE cells are available. In this study, we utilized an AAV2 random mutation library and high-throughput sequencing to screen AAV vectors （AAV206）capable of specifically targeting RPE cells. Intravitreal injection of the AAV206 vector in mice demonstrated that AAV206 specifically infected RPE cells, whereas AAV2 primarily infects the inner retina. Furthermore, AAV206 exhibited lower immunogenicity and toxicity compared to AAV2. Overexpression of sFLT-1 through AAV206 effectively inhibited the size and leakage of choroidal neovascularization. In summary, AAV206 is an ideal vector for gene therapy targeting RPE cells.

2025-01-29 | GSE271661 | GEO

Homology mediated end joining enables efficient non-viral targeted integration of large DNA templates in primary human T cells

Project description:Adoptive cellular therapy using genetically engineered immune cells holds tremendous promise for the treatment of advanced cancers. While the number of available receptors targeting tumor specific antigens continues to grow, the current reliance on viral vectors for clinical production of engineered immune cells remains a substantial bottleneck limiting translation of promising new therapies. Here, we describe an optimized methodology for efficient CRISPR-Cas9 based, non-viral engineering of primary human T cells that overcomes key limitations of previous approaches. By synergizing temporal optimization of reagent delivery, reagent composition, and integration mechanism, we achieve targeted integration of large DNA cargo at efficiencies nearing those of viral vector platforms with minimal toxicity. CAR-T cells generated using our approach are highly functional and elicit potent anti-tumor cytotoxicity in vitro and in vivo. Importantly, our method is readily adaptable to current Good Manufacturing Practices (cGMP) and clinical scale-up, offering a near-term alternative to the use of viral vectors for production of genetically engineered T cells for cancer immunotherapy.

2024-11-04 | GSE246558 | GEO

Sendai virus is robust and consistent in delivering genes into human pancreatic cancer cells.

Project description:Pancreatic ductal adenocarcinoma (PDAC) is highly intratumorally heterogeneous and has several subtypes. Effective gene delivery to all PDAC cells is essential for modulating gene expression and identifying potential gene-based therapeutic targets in PDAC. Most current gene delivery systems for pancreatic cells are optimized for islet or acinar cells. Lentiviral vectors are the current main gene delivery vectors for PDAC, but their transduction efficiencies vary depending on pancreatic cell type, and are especially poor for the classical subtype of PDAC cells from both primary tumors and cell lines. Herein, we systemically compare transduction efficiencies of glycoprotein G of vesicular stomatitis virus (VSV-G)-pseudotyped lentiviral and Sendai viral vectors in human normal pancreatic ductal and PDAC cells. We find that the Sendai viral vector gives the most robust gene delivery efficiency regardless of PDAC cell type. Therefore, we propose using Sendai viral vectors for transducing ectopic genes into PDAC cells.

2024-04-08 | GSE247243 | GEO

Adenovirus Serotype 5 Vectors Trigger IL-27-Dependent Inhibitory CD4+ T Cell Responses

Project description:Viral vectors are attractive vaccine platforms that elicit robust innate and adaptive immune responses; however, viral vector vaccine candidates vary greatly in their ability to induce protective immunity. Ad5 vectors elicit robust CD8+ T cell responses but typically characterized by an exhausted phenotype. The mechanisms by which Ad5 vectors induce dysfunctional CD8+ T cells have not been fully elucidated. Here we demonstrate that Ad5 vectors, but not Ad26 vectors, elicit exhausted antigen-specific IL-10+PD1+ CD4+ T cells with a dysfunctional transcriptional profile, and these cells effectively suppress CD8+ T cells responses in vivo. Induction of inhibitory CD4+ T cells by Ad5 vectors was associated with increased IL-27 expression, and IL-27 blockade improved CD4+ T cell polyfunctionality. Together our data highlight a novel role for IL-27 in regulating responses to viral vector vaccines.

2016-06-01 | GSE73118 | GEO

The Adeno-Associated Virus 2 (AAV2) genome and Rep 68/78 proteins interact with cellular sites of DNA damage.

Project description:We have previously developed a modified iteration of a viral chromosome conformation capture (V3C-seq) assay to show that the autonomous parvovirus Minute Virus of Mice (MVM) localizes spatially with cellular sites of DNA damage to establish viral replication centers. Similar V3C-seq assays to map AAV genome localization show that both replicating and non-replicating AAV2 genomes in the absence of helper virus colocalize with cellular sites of DNA damage. The AAV non-structural protein Rep 68/78, when ectopically expressed in the absence of viral infection or during AAV2 infection in the absence of helper proteins also localizes to cellular sites of DNA damage. Strikingly however, recombinant AAV gene therapy vector genomes derived from AAV do not colocalize with AAV and Rep at cellular DDR sites.

2021-10-20 | GSE178316 | GEO

The global responses of human bone marrow-derived mesenchymal stem cells to baculovirus transduction

Project description:Human mesenchymal stem cells (hMSCs) are a promising cell source for regenerative medicine and can be genetically modified with viral vectors, yet how hMSCs respond to viral vector transduction remains poorly understood, leaving the safety concerns unaddressed. Hereby we explored the responses of hMSCs against an emerging DNA viral vector, baculovirus (BV), and uncovered that BV transduction perturbed the transcription of 816 known genes associated with several signaling pathways.

2009-04-30 | GSE15810 | GEO

Adenovirus Serotype 5 Vectors Trigger IL-27-Dependent Inhibitory CD4+ T Cell Responses

2016-06-01 | E-GEOD-73118 | biostudies-arrayexpress